19-4117552-A-T
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PM2PM5PP3
The NM_030662.4(MAP2K2):c.170T>A(p.Phe57Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F57V) has been classified as Pathogenic.
Frequency
Consequence
NM_030662.4 missense
Scores
Clinical Significance
Conservation
Publications
- cardiofaciocutaneous syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- cardiofaciocutaneous syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- neurofibromatosis-Noonan syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Noonan syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_030662.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MAP2K2 | NM_030662.4 | MANE Select | c.170T>A | p.Phe57Tyr | missense | Exon 2 of 11 | NP_109587.1 | ||
| MAP2K2 | NM_001440688.1 | c.170T>A | p.Phe57Tyr | missense | Exon 2 of 9 | NP_001427617.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MAP2K2 | ENST00000262948.10 | TSL:1 MANE Select | c.170T>A | p.Phe57Tyr | missense | Exon 2 of 11 | ENSP00000262948.4 | ||
| MAP2K2 | ENST00000394867.9 | TSL:5 | n.609T>A | non_coding_transcript_exon | Exon 1 of 10 | ||||
| MAP2K2 | ENST00000599345.1 | TSL:5 | n.367T>A | non_coding_transcript_exon | Exon 2 of 7 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
Variant summary: The MAP2K2 c.170T>A (p.Phe57Tyr) variant involves the alteration of a conserved nucleotide. 3/4 in silico tools predict a damaging outcome (SNPs&GO is not captured due to low reliability index). This variant is absent from 121104 control chromosomes. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories, nor evaluated for functional impact by in vivo/vitro studies. The Phe57 codon is conserved across species and appears to be a mutational hot spot; alterations of this codon (Phe57Cys, Phe57Ile, Phe57Leu, and Phe57val) were reported in multiple individuals diagnosed with CFC, suggesting that missense changes at this residue are not tolerated. Taken together, the variant was classified as VUS-Possibly Pathogenic until additional information becomes available.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at